The 340B Drug Pricing Program was designed to help hospitals serving low-income communities with discounted drugs.

Like so many others, it has metastasized into a wildly expensive welfare program and, effectively, a profit center for well-off hospitals.

Each year that goes by without Congress changing how Medicare pays doctors is a year that deprives countless patients—especially seniors—timely access to care.

One one hand, the One Big Beautiful Bill July reconciliation package restores fiscal responsibility, tackles fraud, and empowers patients through direct primary care. But price controls, extensions to pandemic-era programs, and widespread fraud threaten to undermine all that progress.